Abstract
Cryptosporidium is an opportunistic protozoan parasite of humans and animals worldwide and causes diarrheal disease that is typically self-limiting in immunocompetent hosts but often life threatening to immunocompromised individuals. However, there is a lack of completely efficient therapy available. Probiotics have attracted the attention as potential antiparasite compounds against protozoa involved in intestinal infections. This study investigated the effects of administration of probiotic Enterococcus faecalis CECT 7121 on Cryptosporidium parvum infection in immunosuppressed mice. Effects on C. parvum infection at the intestinal mucosa were studied and scored at each portion of the gut. It was demonstrated that Ef CECT 7121 interfered with C. parvum infection when both probiotic and parasite were present in the same intestinal location suggesting that Ef CECT 7121 supplementation can alleviate the negative effects of C. parvum infection.


Similar content being viewed by others
References
Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23:37–46
Alak JI, Wolf BW, Mdurvwa EG et al (1997) Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in murine model of immunodeficiency syndrome. J Infect Dis 175:218–221
Alak JI, Wolf BW, Mdurvwa EG, Pimentel et al (1999) Supplementation with Lactobacillus reuteri or L. Acidophilus reduced intestinal shedding of Cryptosporidium parvum oocysts in immunodeficient C57BL/6mice. Cell Mol Biol (Noisy-le-grand) 45:855–863
Basualdo J, Sparo M, Chiodo P et al (2007) Oral treatment with a potential probiotic (Enterococcus faecalis CECT7121) appears to reduce the parasite burden of mice infected with Toxocara canis. Ann Trop Med Parasitol 101:559–562
Benyacoub J, Pérez PF, Rochat F et al (2005) Enterococcus faecium SF68 enhances the immune response to Giardia intestinalis in mice. J Nutr 135:1171–1176
Bukhari Z, Smith HV (1995) Effect of three concentration techniques on viability of Cryptosporidium parvum oocysts recovered from bovine feces. J Clin Microbiol 33:2592–2595
de Avila LF, Conceição FR, Telmo PL et al (2012) Saccharomyces boulardii reduces infection intensity of mice with toxocariasis. Vet Parasitol 187:337–340
Del Coco VF (2015) Microorganisms conferring beneficial health effects. Rev Argent Microbiol 47:171–173
Del Coco VF, Córdoba MA, Basualdo JA (2009) Cryptosporidiosis: an emerging zoonosis. Rev Argent Microbiol 41:185–196
Del Coco VF, Córdoba MA, Sidoti A et al (2012) Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice. Vet Parasitol 190:411–417
Goyal N, Tiwari RP, Shukla G (2011) Lactobacillus rhamnosus GG as an effective probiotic for murine giardiasis. Interdiscip Perspect Infect Dis 795219
Goyal N, Rishi P, Shukla G (2013) Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study. World J Microbiol Biotechnol 29:1049–1057
Guitard J, Menotti J, Desveaux A (2006) Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats. Parasitol Res 99:522–527
Heyman MB, Shigekuni LK, Ammann AJ (1986) Separation of Cryptosporidium oocysts from fecal debris by density gradient centrifugation and glass bead columns. J Clin Microbiol 23:789–791
Humen MA, De Antoni GL, Benyacoub J (2005) Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun 73:1265–1269
Merquior VLC, Peralta JM, Facklam RR et al (1994) Analysis of electrophoretic whole-cell protein profiles as a tool for characterization of Enterococcus species. Curr Microbiol 28:149–153
National Research Council (1996) Guide for the care and use of laboratory animals Institute of Laboratory Animal Resources. National Academy Press, Washington DC
Oelschlaeger TA (2010) Mechanisms of probiotic actions—a review. Int J Med Microbiol 300:57–62
Pavan S, Desreumaux P, Mercenier A (2003) Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol 10:696–701
Persing DH, Smith TF, Tanover FC (2008) Diagnostic molecular biology, principles and application. ASM Press, Washington DC
Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 124:45–53
Santín M, Trout JM, Fayer R (2008) A longitudinal study of cryptosporidiosis in dairy cattle from birth to 2 years of age. Vet Parasitol 155:15–23
Smith HV, Nichols RAB, Grimason AM (2005) Cryptosporidium excystation and invasion: getting the guts of the matter. Trends Parasitol 21:133–142
Sparo M, Sanchez Bruni S (2011) Novel immune pharmacological approaches for the treatment of bacterial invasive infections. In: Mendez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances, 1st edn. Formatex, Badajoz, pp 135–143
Sparo MD, Castro MS, Andino PJ et al (2006) Partial characterization of enterocin MR99 from a corn silage isolated of Enterococcus faecalis. J Appl Microbiol 100:123–134
Sparo M, Nuñez GG, Castro M et al (2008) Characteristics of an environmental strain, Enterococcus faecalis CECT7121, and its effects as additive on craft dry-fermented sausages. Food Microbiol 25:607–615
Stockdale HD, Spencer J, Blagburn B (2008) Prophylaxis and chemotherapy. In: Fayer R, Xiao L (eds) Cryptosporidium and cryptosporidiosis, 2nd edn. CRC Press, New York, pp 255–287
Sulaiman IM, Hira PR, Zhou L et al (2005) Unique endemicity of cryptosporidiosis in children in Kuwait. J Clin Microbiol 43:2805–2809
Suzzi G, Caruso M, Gardini F et al (2000) A survey of the enterococci isolated from an artisanal Italian goat’s cheese (semicotto caprino). J Appl Microbiol 89:267–274
Travers MA, Florent I, Kohl L (2011) Probiotics for the control of parasites: an overview. J Parasitol Res 610769
Van Niel CW, Feudtner C, Garrison MM et al (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109:678–684
Waters WR, Harp JA, Wannemuehler MJ et al (1999) Effects of Lactobacillus reuteri on Cryptosporidium parvum infection of gnotobiotic TCR-a-deficient mice. J Eukaryot Microbiol 46:60S–61S
Acknowledgments
This work was supported by Universidad Nacional de La Plata.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Rights and permissions
About this article
Cite this article
Del Coco, V.F., Sparo, M.D., Sidoti, A. et al. Effects of Enterococcus faecalis CECT 7121 on Cryptosporidium parvum infection in mice. Parasitol Res 115, 3239–3244 (2016). https://doi.org/10.1007/s00436-016-5087-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-016-5087-1


